ConductScience.org, home

Paper23398482

Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis.

Teuffel O and 5 others. Br J Haematol, 2013. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis. Papers, record 23398482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23398482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis.
PubMed
Journal
Br J Haematol
PubMed
Year
2013
PubMed
Publication types
Comparative Study, Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2025-07-11
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Teuffel OOliver
2Leibundgut KKurt
3Lehrnbecher TThomas
4Alonzo TATodd A
5Beyene JJoseph
6Sung LLillian

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibiotics, AntineoplasticMajor topic
DaunorubicinMajor topic
IdarubicinMajor topic
Leukemia, Myeloid, AcuteMajor topic
Adult
Child
Child, Preschool
Disease-Free Survival
Dose-Response Relationship, Drug
Female
Humans
Infant
Male
Middle Aged
Remission Induction
Survival Rate

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
87719Canadian Institutes of Health ResearchCanadaPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03023384Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AMLBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
40427048Advances in the Treatment of Acute Myeloid Leukemia: Implications for Low- and Middle-Income Countries.Biomedicines2025https://conductscience.org/library/papers/40427048PubMed
40136430The Application and Molecular Mechanisms of Mitochondria-Targeted Antioxidants in Chemotherapy-Induced Cardiac Injury.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40136430PubMed
39555737Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.Am J Hematol2025https://conductscience.org/library/papers/39555737PubMed
39415901Acute myeloid leukemia presenting with hepatic dysfunction: Should induction be dose reduced?EJHaem2024https://conductscience.org/library/papers/39415901PubMed
38321873Real-world treatment outcomes from a retrospective cohort of patients with acute myeloid leukemia from an urban safety net hospital.J Oncol Pharm Pract2025https://conductscience.org/library/papers/38321873PubMed
38290791Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage.Toxicol Sci2024https://conductscience.org/library/papers/38290791PubMed
38095652The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/38095652PubMed
38066853Improving long-term outcomes with intensive induction chemotherapy for patients with AML.Hematology Am Soc Hematol Educ Program2023https://conductscience.org/library/papers/38066853PubMed
37212948
Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapy.
Int J Hematol2023https://conductscience.org/library/papers/37212948PubMed
36765533At What Point Are Long-Term (>5 Years) Survivors of APL Safe? A Study from the SEER Database.Cancers (Basel)2023https://conductscience.org/library/papers/36765533PubMed
35833221Adverse drug reactions associated with doxorubicin and epirubicin: A descriptive analysis from VigiBase.J Oncol Pharm Pract2026https://conductscience.org/library/papers/35833221PubMed
35680595[Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study].Zhonghua Xue Ye Xue Za Zhi2022https://conductscience.org/library/papers/35680595PubMed
35526025The dual role of autophagy in acute myeloid leukemia.J Hematol Oncol2022https://conductscience.org/library/papers/35526025PubMed
33407700Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.J Hematol Oncol2021https://conductscience.org/library/papers/33407700PubMed
32911532BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells.Blood2021https://conductscience.org/library/papers/32911532PubMed
32635428Intercellular Mitochondrial Transfer in the Tumor Microenvironment.Cancers (Basel)2020https://conductscience.org/library/papers/32635428PubMed
31780390Current treatment preferences in acute myeloid leukemia: a survey in Brazil.Hematol Transfus Cell Ther2020https://conductscience.org/library/papers/31780390PubMed
30968179Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.Cancer Chemother Pharmacol2019https://conductscience.org/library/papers/30968179PubMed
29683259Genital ulcers as diagnostic clue for acute myeloid leukaemia.Int Wound J2018https://conductscience.org/library/papers/29683259PubMed
29043232Comparison of the effects of early intensified induction chemotherapy and standard 3+7 chemotherapy in adult patients with acute myeloid leukemia.Blood Res2017https://conductscience.org/library/papers/29043232PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23398482

GET https://conductscience.org/api/papers/v1/23398482/cited_by?page=2